Please use this identifier to cite or link to this item:
|Title:||Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease|
|Authors:||Neef, Pieter;McDonald, Christine F;Burrell, Louise M;Irving, LB;Johnson, DF;Steinfort, DP|
|Citation:||Internal Medicine Journal 2016; 46(11): 1336-1340|
|Abstract:||The use of beta-blockers in patients with chronic obstructive pulmonary disease and co-morbid cardiovascular disease is controversial, despite increasing evidence to support their use as safe and efficacious. This study retrospectively assessed the rates of beta-blocker prescription in patients admitted to two Australian tertiary hospitals for acute exacerbation of chronic obstructive pulmonary disease. This revealed that less than half of patients (45%) with known cardiac indications were receiving beta-blocker therapy, evident across all degrees of airways disease severity. Further work is needed to ensure that medical management of this patient group is optimised.|
Chronic obstructive pulmonary disease
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.